[Complications of B.C.G. vaccination].
Mande
R
R
Fillastre
C
C
Pinelli
L
L
D000367:Age Factors; D001500:BCG Vaccine / Q000008:administration & dosage / Q000009:adverse effects*; D002626:Chemistry, Pharmaceutical; D002648:Child; D002675:Child, Preschool; D005260:Female; D006291:Health Policy; D006801:Humans; D006967:Hypersensitivity / Q000453:epidemiology / Q000209:etiology; D017589:Immunization Programs / Q000458:organization & administration; D007223:Infant; D007231:Infant, Newborn; D007271:Injections, Intradermal; D008199:Lymphadenitis / Q000453:epidemiology / Q000209:etiology; D008297:Male; D010297:Paris / Q000453:epidemiology; D010865:Pilot Projects; D015397:Program Evaluation; D035583:Rare Diseases; D012189:Retrospective Studies; D013492:Suppuration; D014611:Vaccination / Q000009:adverse effects* / Q000379:methods
D001500:BCG Vaccine